ProfileGDS4718 / 1553226_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 24% 26% 25% 26% 23% 19% 24% 30% 22% 24% 21% 24% 25% 24% 26% 27% 22% 28% 28% 28% 27% 18% 25% 29% 22% 23% 24% 22% 19% 30% 30% 25% 26% 18% 23% 24% 28% 24% 25% 23% 24% 33% 26% 28% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.2900924
GSM549102patient 115, normal, homogenized [OPG study]4.3769326
GSM549104patient 119, normal, homogenized [OPG study]4.3185225
GSM549108patient 138, normal, homogenized [OPG study]4.4335626
GSM549119patient 077, normal, homogenized [OPG study]4.2572423
GSM549133patient 032, cancer, homogenized [OPG study]4.0483619
GSM549139patient 042, cancer, homogenized [OPG study]4.2711124
GSM549099patient 107, normal, homogenized [OPG study]4.5819630
GSM549109patient 139, normal, homogenized [OPG study]4.2397222
GSM549110patient 046, normal, homogenized [OPG study]4.3196424
GSM549114patient 063, normal, homogenized [OPG study]4.141621
GSM549122patient 082, normal, homogenized [OPG study]4.3212924
GSM549134patient 033, cancer, homogenized [OPG study]4.3266125
GSM549136patient 036, cancer, homogenized [OPG study]4.2427124
GSM549140patient 044, cancer, homogenized [OPG study]4.3279926
GSM549111patient 047, normal, homogenized [OPG study]4.386327
GSM549113patient 057, normal, homogenized [OPG study]4.1586222
GSM549132patient 031, cancer, homogenized [OPG study]4.4358328
GSM549137patient 038, cancer, homogenized [OPG study]4.4603928
GSM549142patient 047, cancer, homogenized [OPG study]4.566528
GSM549100patient 110, normal, homogenized [OPG study]4.4245627
GSM549107patient 135, normal, homogenized [OPG study]4.0450818
GSM549115patient 068, normal, homogenized [OPG study]4.2768225
GSM549116patient 072, normal, homogenized [OPG study]4.4964829
GSM549120patient 078, normal, homogenized [OPG study]4.2022222
GSM549131patient 030, cancer, homogenized [OPG study]4.2210423
GSM549118patient 074, normal, homogenized [OPG study]4.3087824
GSM549129patient 027, cancer, homogenized [OPG study]4.2160522
GSM549123patient 088, normal, homogenized [OPG study]4.1126719
GSM549124patient 006, cancer, homogenized [OPG study]4.599730
GSM549126patient 015, cancer, homogenized [OPG study]4.5383730
GSM549128patient 025, cancer, homogenized [OPG study]4.3220425
GSM549103patient 117, normal, homogenized [OPG study]4.4218626
GSM549117patient 073, normal, homogenized [OPG study]4.0601718
GSM549138patient 041, cancer, homogenized [OPG study]4.2198423
GSM549141patient 045, cancer, homogenized [OPG study]4.2407824
GSM549130patient 028, cancer, homogenized [OPG study]4.4581928
GSM549101patient 111, normal, homogenized [OPG study]4.3149924
GSM549105patient 128, normal, homogenized [OPG study]4.3511725
GSM549106patient 134, normal, homogenized [OPG study]4.2229523
GSM549112patient 048, normal, homogenized [OPG study]4.2933124
GSM549125patient 011, cancer, homogenized [OPG study]4.6820233
GSM549127patient 024, cancer, homogenized [OPG study]4.3544826
GSM549135patient 035, cancer, homogenized [OPG study]4.3921928